Fundraising Fox
Ifmthera
Cambridge, US · Founded 2015 · 11 employees on LinkedIn · 2 known investors
Find your way into Ifmthera
Sign up to see every warm intro you have to Ifmthera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ifmthera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IFM Therapeutics develops small-molecule drugs that target the innate immune system to treat inflammation-driven diseases and cancer. The company operates through independently financed R&D subsidiaries, each advancing programs aimed at key control nodes of innate immunity such as NLRP3 and cGAS/STING.
Founders & leadership
Ifmthera was founded in 2015 by Gary D. Glick.
Board
Investors · 2
How we know: Atlas Venture's portfolio page · the company's own site · a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$17.1M disclosed across 1 round · 2016
▶$17.1MraisedJun 2016 · 4 investors · BiotechnologyRule 506(b)
- Gary GlickExecutive Officer, Director
- Jean-Francois FormelaDirector
- Amount sold
- $17.1M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Ifmthera went on to found or lead other companies.
Frequently asked questions
- What does Ifmthera do?
- IFM Therapeutics develops small-molecule drugs that target the innate immune system to treat inflammation-driven diseases and cancer. The company operates through independently financed R&D subsidiaries, each advancing programs aimed at key control nodes of innate immunity such as NLRP3 and cGAS/STING.
- Who founded Ifmthera?
- Ifmthera was founded by Gary D. Glick in 2015.
- Who are Ifmthera's investors?
- Ifmthera's investors include Atlas Venture, Abingworth.
- How much funding has Ifmthera raised?
- Ifmthera has disclosed $17.1M raised across 1 round.
- Where is Ifmthera headquartered?
- Ifmthera is headquartered in Cambridge, US.